Literature DB >> 15583133

Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral proteins.

Marisa P McShane1, Richard Longnecker.   

Abstract

Epstein-Barr virus (EBV) infects human B lymphocytes and epithelial cells. We have compared the requirements for EBV glycoprotein-induced cell fusion between Chinese hamster ovary effecter cells and human B lymphoblasts or epithelial cells by using a virus-free cell fusion assay. EBV-encoded gB, gH, gL, and gp42 glycoproteins were required for efficient B cell fusion, whereas EBV gB, gH, and gL glycoproteins were required for Chinese hamster ovary effecter cell fusion with epithelial cell lines (AGS and SCC68) or the human embryonic kidney cell line 293-P. Fusion with human embryonic kidney 293-P cells was greater than fusion observed with B cells, indicative of an important role for cell contact. An antibody directed against the gH and gL complex inhibited epithelial cell fusion. Increased surface expression of gB alone as a result of truncations or point mutants in the carboxyl-terminal tail allowed gB-mediated fusion with epithelial cells, albeit at a lower level than with coexpression of gB, gH, and gL. Overall, gB appears to be the critical component for EBV glycoprotein-mediated cell fusion.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15583133      PMCID: PMC536015          DOI: 10.1073/pnas.0404535101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  56 in total

1.  Infection of breast epithelial cells with Epstein-Barr virus via cell-to-cell contact.

Authors:  P Speck; R Longnecker
Journal:  J Natl Cancer Inst       Date:  2000-11-15       Impact factor: 13.506

2.  Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.

Authors:  A Janz; M Oezel; C Kurzeder; J Mautner; D Pich; M Kost; W Hammerschmidt; H J Delecluse
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Epstein-Barr virus lacking glycoprotein gp85 cannot infect B cells and epithelial cells.

Authors:  T Oda; S Imai; S Chiba; K Takada
Journal:  Virology       Date:  2000-10-10       Impact factor: 3.616

4.  Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells.

Authors:  Martin I Muggeridge
Journal:  J Gen Virol       Date:  2000-08       Impact factor: 3.891

Review 5.  Function of glycoprotein B homologues of the family herpesviridae.

Authors:  L Pereira
Journal:  Infect Agents Dis       Date:  1994-02

6.  Effects of truncation of the carboxy terminus of pseudorabies virus glycoprotein B on infectivity.

Authors:  R Nixdorf; B G Klupp; A Karger; T C Mettenleiter
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

7.  Pseudorabies virus glycoprotein M inhibits membrane fusion.

Authors:  B G Klupp; R Nixdorf; T C Mettenleiter
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Role of the cytoplasmic tails of pseudorabies virus glycoproteins B, E and M in intracellular localization and virion incorporation.

Authors:  Ralf Nixdorf; Barbara G Klupp; Thomas C Mettenleiter
Journal:  J Gen Virol       Date:  2001-01       Impact factor: 3.891

9.  Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells.

Authors:  S J Molesworth; C M Lake; C M Borza; S M Turk; L M Hutt-Fletcher
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

10.  Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells.

Authors:  X Wang; W J Kenyon; Q Li; J Müllberg; L M Hutt-Fletcher
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more
  48 in total

1.  Glycoprotein B of herpes simplex virus 2 has more than one intracellular conformation and is altered by low pH.

Authors:  Martin I Muggeridge
Journal:  J Virol       Date:  2012-04-18       Impact factor: 5.103

2.  Crystal structure of the Epstein-Barr virus (EBV) glycoprotein H/glycoprotein L (gH/gL) complex.

Authors:  Hisae Matsuura; Austin N Kirschner; Richard Longnecker; Theodore S Jardetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-13       Impact factor: 11.205

3.  Soluble Epstein-Barr virus glycoproteins gH, gL, and gp42 form a 1:1:1 stable complex that acts like soluble gp42 in B-cell fusion but not in epithelial cell fusion.

Authors:  Austin N Kirschner; Jasmina Omerovic; Boris Popov; Richard Longnecker; Theodore S Jardetzky
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion.

Authors:  Liguo Wu; Lindsey M Hutt-Fletcher
Journal:  Virology       Date:  2007-02-20       Impact factor: 3.616

Review 5.  Epstein-Barr virus entry.

Authors:  Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2007-04-25       Impact factor: 5.103

6.  Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion.

Authors:  Austin N Kirschner; Amanda S Lowrey; Richard Longnecker; Theodore S Jardetzky
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

7.  Characterization of EBV gB indicates properties of both class I and class II viral fusion proteins.

Authors:  Marija Backovic; George P Leser; Robert A Lamb; Richard Longnecker; Theodore S Jardetzky
Journal:  Virology       Date:  2007-07-25       Impact factor: 3.616

8.  Mutations of Epstein-Barr virus gH that are differentially able to support fusion with B cells or epithelial cells.

Authors:  Liguo Wu; Corina M Borza; Lindsey M Hutt-Fletcher
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Functional homology of gHs and gLs from EBV-related gamma-herpesviruses for EBV-induced membrane fusion.

Authors:  Jasmina Omerović; Richard Longnecker
Journal:  Virology       Date:  2007-05-02       Impact factor: 3.616

10.  The BDLF2 protein of Epstein-Barr virus is a type II glycosylated envelope protein whose processing is dependent on coexpression with the BMRF2 protein.

Authors:  Mindy Gore; Lindsey M Hutt-Fletcher
Journal:  Virology       Date:  2008-11-07       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.